ClinicalTrials.Veeva

Menu

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Refractory Epilepsy (ANT-DBS-RE)

B

Beijing Pins Medical

Status

Unknown

Conditions

Refractory Epilepsy

Treatments

Procedure: PINS'Deep Brain Stimulator device

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02602899
PINS-013

Details and patient eligibility

About

Evaluate the long-term clinical effectiveness and safety of the PINS Deep Brain Stimulation to patients with refractory epilepsy.

Enrollment

30 estimated patients

Sex

All

Ages

12 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 12-60.
  • having tried at least two appropriate anti-epileptic drugs (AEDs) tested to tolerance or to blood levels at upper end of the target range of which at least 2 have been tolerated at normal dose.
  • at least 6 seizures per month.
  • in good health except epilepsy.
  • to with normal MMSE score
  • patients or his(her) familys could understand this method and sign the informed consent 7)Patients with good compliance and could complete postoperative follow-up

Exclusion criteria

  • results of MRI remind epilepsy caused by intracranial space-occupying lesions.
  • the vagus nerve lesion and damage
  • tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma,mental disease,peptic ulcer,diabetes Type 1,bad health etc, and other surgical contraindication.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

PINS Deep Brain Stimulator
Experimental group
Description:
Deep Brain Stimulator is on,continuous stimulation to the brain,
Treatment:
Procedure: PINS'Deep Brain Stimulator device

Trial contacts and locations

1

Loading...

Central trial contact

Fumin Jia; Luming Li

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems